The Top 100 Most Frequently Cited Publications Concerning Anti-PD-1/PD-L1 Therapy for Lung Cancer: A Bibliometric Analysis

Abstract

Background Globally lung cancer is one of the most common cancers, and is responsible for almost 20% of all cancer care costs. As a potential treatment for lung cancer, anti-PD-1/PD-L1 therapy has become a novel scientific hotspot in recent decades. The present study aims at exploring the status and trends of the top frequently cited publications about the anti-PD-1/PD-L1 therapy for lung cancer via bibliometric analysis. Methods The publications concerning anti-PD-1/PD-L1 therapy for lung cancer were searched on the core collection database of Web of Science, setting the time period for retrieval from 1950 to 2019. The top 100 most frequently cited publications were retrieved, and the bibliometric data were mainly accessed through an open online analysis platform and VOSviewer software. Results The cited frequencies about the top 100 cited publications ranged from 218 to 6248. These articles were published in 39 publications, which were mainly ranked in Q1. The top journal in terms of the number of the articles was the New England Journal of Medicine (16 articles). The most frequently nominated author was Brahmer, JR from Sidney Kimmel Comprehensive Cancer Center, while the most contributing institution was Memorial Sloan Kettering Cancer. The United States acted as the pioneer in this new field of research and led plentiful of national and international co-operations. Immunotherapy, nivolumab, cell lung-cancer, safety, and docetaxel appeared more frequently as keywords. Discussions To sum up, high quality journals, influential authors and institutions and research with high quality evidence were apt to attract more attention and possess more public credibility. Moreover, the bibliometric analysis is yielding up its advantage of identifying and analyzing the characteristics and changes in the intellectual structures of a special topic.

Tooth auto‐transplantation: A bibliometric analysis of the top 100 most‐cited articles

“…The sample size of the top 100 mostcited articles correlates to the methodology used in previous bibliometric studies in the Medicine and Dentistry. 11,17,30,31 In this study, the WoS-CC database was adopted as a benchmark for citation counts, in line with previous bibliometric studies. 15,22 Furthermore, the WoS database is considered one of the most renowned citation databases that harnesses a collection of several cross-searchable databases measuring scientific article citations over an extensive time span.…”

Research Trends and Most Influential Clinical Studies on Anti-PD1/PDL1 Immunotherapy for Cancers: A Bibliometric Analysis

“…However, many frequently cited important randomized clinical trials were not included in this analysis ( 8 , 13 – 17 ). Other bibliometric analyses only performed cursory searches and did not distinguish between clinical studies, reviews, and basic research ( 18 , 19 ). All these studies only performed basic analyses and listed superficial information, but lacked intuitive visualization and in-depth discussion.…”

Global research landscape and trends of lung cancer immunotherapy: A bibliometric analysis

“…In recent years, bibliometric analysis has become increasingly popular in medical research ( 7 , 8 ). Two bibliometric analyses related to lung cancer immunotherapy have been published ( 2 , 9 ). However, the first included only papers published before March 2020, which is more than 2 years before the present study was conducted ( 9 ).…”

“…Two bibliometric analyses related to lung cancer immunotherapy have been published ( 2 , 9 ). However, the first included only papers published before March 2020, which is more than 2 years before the present study was conducted ( 9 ). The latter analyzed all articles related to anti–PD–(L)1 for cancer immunotherapy, without limitation of the type of cancer ( 2 ).…”